Home RxNorm 1874537 {7 (ethinyl estradiol 0.01 MG Oral Tablet) / 42 (ethinyl estradiol 0.02 MG / levonorgestrel 0.15 MG Oral Tablet) / 21 (ethinyl estradiol 0.025 MG / levonorgestrel 0.15 MG Oral Tablet) / 21 (ethinyl estradiol 0.03 MG / levonorgestrel 0.15 MG Oral Tablet) } Pack [Fayosim 91 Day] Drug identity information. FDA.report links public drug records from RxNav, DailyMed, FDA NDC, Drugs@FDA, and related public sources where available. This page is informational only and is not medical, prescribing, or regulatory advice.
RxCUI 1874537
RxNorm name {7 (ethinyl estradiol 0.01 MG Oral Tablet) / 42 (ethinyl estradiol 0.02 MG / levonorgestrel 0.15 MG Oral Tablet) / 21 (ethinyl estradiol 0.025 MG / levonorgestrel 0.15 MG Oral Tablet) / 21 (ethinyl estradiol 0.03 MG / levonorgestrel 0.15 MG Oral Tablet) } Pack [Fayosim 91 Day]
Display name FAYOSIM 91 DAY (Pack)
Full name {7 (ethinyl estradiol 0.01 MG Oral Tablet) / 42 (ethinyl estradiol 0.02 MG / levonorgestrel 0.15 MG Oral Tablet) / 21 (ethinyl estradiol 0.025 MG / levonorgestrel 0.15 MG Oral Tablet) / 21 (ethinyl estradiol 0.03 MG / levonorgestrel 0.15 MG Oral Tablet) } Pack [Fayosim 91 Day]
Term type BPCK
Status Active
Strength mixed
Dose form Pack
Route Pack
Updated 2026-11-16 14:58:43 RxNorm Status History#
Status Active
Source RXNORM
Current YES
Release start 042017
Active start 042017
Multiple ingredient YES
Branded YES
Ingredients And Strength# Derived Ingredient Concepts# RxNav Current And Historical NDCs# RxNav current and historical NDC rows page 1 of 1 · 3 matching rows.
NDC11, Source, Active table NDC11 Source Active 68180086011 rxnav_ndcs yes 68180086012 rxnav_ndcs yes 68180086013 rxnav_historical
UNII Substances# UNII substance links page 1 of 1 · 0 matching rows.
No records found.
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed RxNorm Mappings# unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 0 matching rows.
No records found.
Recently Linked DailyMed Labels# Set ID, Title, Manufacturer table Set ID Title Manufacturer Effective f49d3256-f665-45ff-a096-3c0fb5979d16 These highlights do not include all the information needed to use FAYOSIM safely and effectively. See full prescribing information for FAYOSIM. FAYOSIM™ (levonorgestrel and ethinyl estradiol tablets USP, and ethinyl estradiol tablets USP), for oral use Initial U.S. Approval: 1982 Lupin Pharmaceuticals, Inc. | LUPIN LIMITED 20191213
Drug Classes# Source, Class ID, Class table Source Class ID Class Type Relationship Drug concept ATC G03AD Emergency contraceptives ATC1-4 levonorgestrel ATC L02AA Estrogens ATC1-4 ethinyl estradiol ATC G03CA Natural and semisynthetic estrogens, plain ATC1-4 ethinyl estradiol ATC G03AC Progestogens ATC1-4 levonorgestrel ATC G03AA Progestogens and estrogens, fixed combinations ATC1-4 ethinyl estradiol / levonorgestrel ATC G03AB Progestogens and estrogens, sequential preparations ATC1-4 ethinyl estradiol / levonorgestrel FDASPL D045167 Progesterone Congeners CHEM has_chemical_structure levonorgestrel FDASPL N0000175825 Estrogen EPC has_epc ethinyl estradiol FDASPL N0000175602 Progestin EPC has_epc levonorgestrel FDASPL N0000175832 Progestin-containing Intrauterine System EPC has_epc levonorgestrel FDASPL N0000000100 Estrogen Receptor Agonists MOA has_moa ethinyl estradiol FDASPL N0000175830 Inhibit Ovum Fertilization PE has_pe levonorgestrel MEDRT D004997 Ethinyl Estradiol CHEM has_ingredient ethinyl estradiol MEDRT D016912 Levonorgestrel CHEM has_ingredient levonorgestrel MEDRT D000022 Abortion, Spontaneous DISEASE induces levonorgestrel MEDRT D018248 Adenoma, Liver Cell DISEASE ci_with levonorgestrel MEDRT D001943 Breast Neoplasms DISEASE ci_with ethinyl estradiol MEDRT D001943 Breast Neoplasms DISEASE may_treat ethinyl estradiol MEDRT D001943 Breast Neoplasms DISEASE ci_with levonorgestrel MEDRT D002539 Cerebral Arterial Diseases DISEASE ci_with ethinyl estradiol MEDRT D002561 Cerebrovascular Disorders DISEASE ci_with levonorgestrel MEDRT D003324 Coronary Artery Disease DISEASE ci_with ethinyl estradiol MEDRT D003327 Coronary Disease DISEASE ci_with levonorgestrel MEDRT D003920 Diabetes Mellitus DISEASE ci_with levonorgestrel MEDRT D004342 Drug Hypersensitivity DISEASE ci_with ethinyl estradiol MEDRT D004342 Drug Hypersensitivity DISEASE ci_with levonorgestrel MEDRT D016889 Endometrial Neoplasms DISEASE ci_with ethinyl estradiol MEDRT D016889 Endometrial Neoplasms DISEASE ci_with levonorgestrel MEDRT D020773 Headache Disorders DISEASE ci_with levonorgestrel MEDRT D006349 Heart Valve Diseases DISEASE ci_with levonorgestrel MEDRT D019584 Hot Flashes DISEASE may_treat ethinyl estradiol MEDRT D006973 Hypertension DISEASE ci_with levonorgestrel MEDRT D006973 Hypertension DISEASE ci_with ethinyl estradiol MEDRT D007006 Hypogonadism DISEASE may_treat ethinyl estradiol MEDRT D007565 Jaundice DISEASE ci_with levonorgestrel MEDRT D007674 Kidney Diseases DISEASE ci_with levonorgestrel MEDRT D008107 Liver Diseases DISEASE ci_with ethinyl estradiol MEDRT D008107 Liver Diseases DISEASE ci_with levonorgestrel MEDRT D008113 Liver Neoplasms DISEASE ci_with levonorgestrel MEDRT D008594 Menopause, Premature DISEASE may_treat ethinyl estradiol MEDRT D008595 Menorrhagia DISEASE may_treat ethinyl estradiol MEDRT D009376 Neoplasms, Hormone-Dependent DISEASE ci_with ethinyl estradiol MEDRT D015663 Osteoporosis, Postmenopausal DISEASE may_prevent ethinyl estradiol MEDRT D011247 Pregnancy DISEASE may_prevent ethinyl estradiol MEDRT D011247 Pregnancy DISEASE may_prevent levonorgestrel MEDRT D011247 Pregnancy DISEASE ci_with levonorgestrel MEDRT D011247 Pregnancy DISEASE ci_with ethinyl estradiol MEDRT D016649 Primary Ovarian Insufficiency DISEASE may_treat ethinyl estradiol MEDRT D011471 Prostatic Neoplasms DISEASE may_treat ethinyl estradiol MEDRT D013923 Thromboembolism DISEASE ci_with levonorgestrel MEDRT D013923 Thromboembolism DISEASE ci_with ethinyl estradiol MEDRT D013924 Thrombophlebitis DISEASE ci_with ethinyl estradiol MEDRT D013924 Thrombophlebitis DISEASE ci_with levonorgestrel MEDRT D064424 Tobacco Use DISEASE ci_with ethinyl estradiol MEDRT D014029 Tobacco Use Disorder DISEASE ci_with levonorgestrel MEDRT D014592 Uterine Hemorrhage DISEASE ci_with levonorgestrel MEDRT N0000000100 Estrogen Receptor Agonists MOA has_moa ethinyl estradiol MEDRT N0000000185 Progestational Hormone Receptor Agonists MOA has_moa levonorgestrel MEDRT N0000008311 Bone Formation Stimulation PE has_pe ethinyl estradiol MEDRT N0000008595 Decreased Embryonic Implantation PE has_pe ethinyl estradiol MEDRT N0000008595 Decreased Embryonic Implantation PE has_pe levonorgestrel MEDRT N0000009072 Hypothalamic Endocrine Activity Alteration PE has_pe levonorgestrel MEDRT N0000178478 Increased Blood Pressure PE ci_pe levonorgestrel MEDRT N0000009717 Inhibit Ovulation PE has_pe ethinyl estradiol MEDRT N0000009717 Inhibit Ovulation PE has_pe levonorgestrel MEDRT N0000009902 Vaginal Function Alteration PE has_pe ethinyl estradiol MEDRT N0000008289 Aromatic hydroxylation PK has_pk ethinyl estradiol MEDRT N0000000045 Fecal Excretion PK has_pk ethinyl estradiol MEDRT N0000000026 Hepatic Metabolism PK has_pk ethinyl estradiol MEDRT N0000000042 Renal Excretion PK has_pk ethinyl estradiol
Properties# Category, Property, Value table Category Property Value ATTRIBUTES GENERAL_CARDINALITY MULTI ATTRIBUTES HUMAN_DRUG US NAMES Prescribable Synonym Fayosim 91 Day Pack SOURCES Source Gold Standard Alchemy SOURCES Source Micromedex RED BOOK